Compare
CollPlant Biotechnologies Ltd vs ENvue Medical, Inc. vs NutriBand Inc. vs Anteris Technologies Global Corp.
| Latest fiscal year | CollPlant Biotechnologies Ltd CLGN | ENvue Medical, Inc. FEED | NutriBand Inc. NTRB | Anteris Technologies Global Corp. AVR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-01-31 | 2025-12-31 |
| Revenue | $2.37M | $2.55M | $2.04M | $1.91M |
| Revenue growth (YoY) | +360.4% | -0.2% | -4.8% | -29.2% |
| Gross margin | 64.8% | 6.0% | 27.8% (computed) | 70.3% (computed) |
| Operating margin | -484.3% | -896.6% | -408.4% | n/m |
| Net margin | -484.6% | -712.3% | -404.1% | n/m |
| Net income | -$11.49M | -$18.18M | -$8.23M | -$94.14M |
| EPS (Diluted) | -$0.94 | -$26.69 | -$2.58 | -$2.55 |
| Operating cash flow | -$9.42M | -$9.37M | -$5.13M | -$77.80M |
| Free cash flow | -$9.45M | -$9.43M | -$5.14M | -$79.76M |
| Cash & equivalents | $5.59M | $4.22M | $4.57M | n/a |
| Total assets | $10.79M | $41.12M | $7.55M | $23.00M |
| Total liabilities | $4.70M | $7.63M | $868.4K | $23.25M |
| Shareholders' equity | $6.08M | $33.50M | $6.68M | -$93.0K |
| Return on year-end equity | -188.9% | -54.3% | -123.2% | n/a |
| Shares outstanding | 12.80M | 1.10M | 12.16M | 41.58M |
Revenue, most recent five fiscal years
| Fiscal year | CollPlant Biotechnologies Ltd | ENvue Medical, Inc. | NutriBand Inc. | Anteris Technologies Global Corp. |
|---|---|---|---|---|
| Latest | $2.37M Ended 2025-12-31 | $2.55M Ended 2025-12-31 | $2.04M Ended 2026-01-31 | $1.91M Ended 2025-12-31 |
| 1 year earlier | $515.0K Ended 2024-12-31 | $2.56M Ended 2024-12-31 | $2.14M Ended 2025-01-31 | $2.70M Ended 2024-12-31 |
| 2 years earlier | $10.96M Ended 2023-12-31 | $2.28M Ended 2023-12-31 | $2.09M Ended 2024-01-31 | n/a |
| 3 years earlier | $299.0K Ended 2022-12-31 | $752.0K Ended 2022-12-31 | $2.08M Ended 2023-01-31 | n/a |
| 4 years earlier | $15.64M Ended 2021-12-31 | $1.70M Ended 2021-12-31 | $1.42M Ended 2022-01-31 | n/a |